Merck Will Buy Rights to Neuromed's (Vioxx medication) Experimental Pain Drugs

Merck Will Buy Rights to Neuromed's (Vioxx medication) Experimental Pain Drugs 

Merck Will Buy Rights to Neuromed's Experimental Pain Drugs 
March 20 (Bloomberg) -- Merck & Co. said it has agreed to buy rights to pain drugs being developed by closely held Neuromed Pharmaceuticals Ltd. for as much as $475 million.
Source: www.bloomberg.com

Merck hit with $4.5 jury award over Vioxx 
ATLANTIC CITY, N.J., April 6 (UPI) -- A New Jersey jury hit Merck & Co. with a $4.5 million penalty in a suit over its Vioxx medication.
Source: www.upi.com